chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache; dizziness; body aches; mild fever; chills; extreme fatigue; soreness at injection site; This is a spontaneous report from a contactable other HCP (patient). A 34-year-old non-pregnant female patient received the second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK9231), via an unspecified route of administration on 07Jan2021 at 10:45 at single dose in left arm for covid-19 immunization. Medical history included allergies to penicillin. Concomitant medication included ethinylestradiol, etonogestrel (NUVARING), levothyroxine, desvenlafaxine succinate (PRISTIQ). The patient previously received the first dose bnt162b2 (Batch/lot number: EK5730) on 17Dec2020 at 15:00 in left arm for COVID-19 immunization at age of 33 years old. The patient experienced headache, dizziness, body aches, mild fever, chills, extreme fatigue, and soreness at injection site on 07Jan2021 at 23:00. All events were reported as non-serious by reporter. The patient didn't receive treatment for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination, and has not been tested for COVID-19 since the vaccination. The outcome of all the events was resolved in Jan2021.   No follow-up attempts are possible. No further information is expected.
No treatment from Safeway. Patient had red rash bumps all over his body. His arms, legs, forehead and neck were covered with red rash bumps, and big red rash at injection site.
Into ER with severe pain to shoulder in arm of Pneumovax.  Pain, swelling and limited range of motion.  Ortho saw patient opened shoulder to find purulent drainage.
Rash around injection site that has been slowly growing in size and is 2 inches big 6 days post vaccine
Raised, hot, and painful on the right calf; Varicose Veins bulging out; Pain in the right side of body; Bulge on the injection site; Pain in the left knee; Has No Energy; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Has No Energy), FEELING HOT (Raised, hot, and painful on the right calf), VARICOSE VEIN (Varicose Veins bulging out), PAIN (Pain in the right side of body) and VACCINATION SITE SWELLING (Bulge on the injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939982) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Aug-2021, the patient experienced ASTHENIA (Has No Energy), PAIN (Pain in the right side of body), VACCINATION SITE SWELLING (Bulge on the injection site) and ARTHRALGIA (Pain in the left knee). On 03-Aug-2021, the patient experienced FEELING HOT (Raised, hot, and painful on the right calf) and VARICOSE VEIN (Varicose Veins bulging out). On 06-Aug-2021, FEELING HOT (Raised, hot, and painful on the right calf) and VARICOSE VEIN (Varicose Veins bulging out) had resolved. At the time of the report, ASTHENIA (Has No Energy), PAIN (Pain in the right side of body), VACCINATION SITE SWELLING (Bulge on the injection site) and ARTHRALGIA (Pain in the left knee) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Information has been received from a registered nurse regarding a patient of unknown age and gender. On 03-MAR-2012 at 11:30 ZOSTAVAX, lot # 672477/1604AA was exposed to -12 C for an estimated total time out of range of 4 hours. On 17-APR-2012 at 7:30am, ZOSTAVAX, lot # 672477/1604AA was exposed to -12 C for an estimated total time out of range of 14 hours. On 03-MAY-2012, the patient was vaccinated with an out of range dose of ZOSTAVAX, lot # 672477/1604AA, expiration date: 13-JAN-2013) (dose and route were not provided). No adverse experience was reported. This is one of 182 reports received from the same source. Additional information has been requested.
2:30 AM 1/30/21  chills, skin sensitive to touch, fever, extreme headaches, dizziness, nausea, redness at site of injection
Initial information received on 20-Aug-2018 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves patient (age and gender unknown) who experienced headaches, while received vaccines SHINGRIX and FLUZONE. The patient's past medical history, concomitant medication and family history were not provided. On an unknown date, the patient received injection of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number, expiry date and dose not reported via unknown route in unknown administration site. On an unknown date, the patient received injection of suspect SHINGRIX not produced by Sanofi Pasteur lot number, expiry date and dose not reported via unknown route in unknown administration site. The patient was given FLUZONE and SHINGRIX vaccine at the same time. On an unknown date, the patient developed a non-serious headaches but seems fine otherwise with unknown latency following the administration of INFLUENZA QUADRIVAL A-B VACCINE and following the administration of SHINGRIX. No lab data was provided. Final diagnosis was headaches. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for headaches. List of documents held by sender- none.
administered 1ml of the vaccine instead of just 0.5ml; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of ACCIDENTAL OVERDOSE (administered 1ml of the vaccine instead of just 0.5ml) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021 at 11:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 06-Mar-2021 at 11:15 AM, the patient experienced ACCIDENTAL OVERDOSE (administered 1ml of the vaccine instead of just 0.5ml). On 06-Mar-2021 at 11:15 AM, ACCIDENTAL OVERDOSE (administered 1ml of the vaccine instead of just 0.5ml) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-035792, US-MODERNATX, INC.-MOD-2021-035848, US-MODERNATX, INC.-MOD-2021-035866 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-035792: US-MODERNATX, INC.-MOD-2021-035848: US-MODERNATX, INC.-MOD-2021-035866:
Tinnitus in both ears. The ringing began the same day that I received the injection. I reported the ear ringing to the CDC for the first time on the same day I received the injection. It was reported via the text messaging app through which the CDC followed vaccine recipients during the days and weeks after the injection.  I discussed with my primary care doctor who referred me to an ENT. The ENT sent me to an audiologist, and then I had a follow up with the ENT. The ringing has not gone away. Its been constant in tone and volume though I think its been worsening over the past week or so.   About 35 years prior I attended a loud rock concert. It resulted in mild ear ringing that was hardly noticeable to me over the years, until March 29, 2021 when I received the Pfizer Covid vaccine.
Patient awakened in the morning with pain and swelling in the right knee with marked tenderness laterally and local swelling in the same area.  Over the next 12 hours she developed a moderate synovial effusion of approximately 20 cc with pain in the knee becomeing generalized and had trouble walking and decreased range of motion consistent with the effusion. .  The pain seemed to subside somewhat later in the day but she still had trouble walking.  On the second night of 2/6/2021 she was able to sleep but had continued discomfort, swelling and difficulty walking on 2/7/2021.  The pain became even worse during the night of 2/7/21 and she was unable to sleep.  In the early morning  she took 5 mg hydrocodone and got some relief.. She continued to have pain and swelling through the day.  By the evening of 27/21 she was somewhat better.  The morning of 2/8 21 she awakened with less pain, less effusion, and was able to walk better.  She slept well that night.  On the morning of 2/9/ she awakened with no pain.  The effusion was gone and the knee felt stiff but no longer was painful.  By afternoon she was walking without pain and complaining of slight stiffness.    The only other side effect was pain at the injection sight for 2 days which was mild to moderate.  The R knee never felt warm and was never red.  .  I have an infrared camera and the temps recorded on the right knee were no higher than the left knee.  No other joints were involved and she had no recent right knee injury.  No chills, fever, nausea or other problems.  No headache, No myalgias. No vision or auditory prob.ems.  The sense of smell remained normal.  She is my wife and I was considering getting a CBC, Sed Rate, C-reactive protein and possibly an arthrocentesis and evaluation of the fluid.  Since she improved markedly and quickly no tests were done.  I will report any follow-up problems.   It just seemed very strange to have a painful swollen joint with no redness or warmth that was fairly severe and then almost totally resolve within 24 hours between the 3rd and forth day.  .
This spontaneous report was received from a health professional via company representative and refers to a 15-year-old female patient. The patient had no pertinent medical history, no drug reactions and no allergies. On 23-OCT-2014, the patient was vaccinated with the first dose of GARDASIL (dose and anatomical location were not reported, lot # J011272, exp. date was not reported). After the vaccination the patient offered no complaints. There was no concomitant therapy. On 06-JAN-2015, the patient was vaccinated with the second dose of GARDASIL (dose and anatomical location were not reported, lot # K006960, exp. date was not reported). On 06-JAN-2015, in the evening, the patient experienced dizziness, nausea and headache. The patient's mother informed her physician that the patient sought medical attention in an unspecified emergency department of an unspecified facility. The patient was not admitted to the hospital and the reporter did not know if the patient received any treatments while in the emergency department. The patient recovered from the adverse events on an unspecified date, approximately in January 2015. The relatedness between vaccination with GARDASIL and the events was not reported. Additional information has been requested.
Felt fine 2:30-12:00am day of vaccination. Around 2am started to feel very hot and overheated. 4:30am began body aches. 7:00am body aches, dizziness, fatigue. Symptoms resolved by 6pm same day.
Makes it difficult to write; The patient developed a blister-like rash on her hands/ The rash is painful and makes it difficult to write; The pharmacist reported that the patient reports that she has never had the chickenpox disease before; Information has been received from a pharmacist, concerning an approximately 19-years old female patient. The patient had no medical history, drug reactions or allergies.  On 11-JUL-2019, the patient was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) Lot # R006221 with expiration date: 29-FEB-2020 (route of administration and anatomical location were not provided) for prophylaxis (reported as "needed the vaccine for nursing school"). The patient was also vaccinated with a dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (MMR II) for prophylaxis (lot number, expiration date, route of administration and anatomical location were not provided), one dose of diphtheria toxoid, pertussis acellular 3-component vaccine, tetanus toxoid (BOOSTRIX) (lot number, expiration date, route of administration, indication and anatomical location were not provided) and one dose of hepatitis B virus vaccine rHBsAg (yeast) (ENGERIX-B) (lot number, expiration date, route of administration, indication and anatomical location were not provided). These vaccines were also reported as concomitant medication.  Subsequently in 12-JUL-2019, the patient developed a "blister-like rash "(rash) on her hands. The rash was painful and made it difficult to write (movement disorder). The patient reported that she never had chickenpox before (varicella). The patient went to an unspecified urgent care clinic on 14-JUL-2019, where she was treated with a 40 mg triamcinolone acetonide (KENALOG) injection. There was no lab diagnostics or studies performed. The patient had not recovered from the abovementioned adverse events at the time of this report.  The causal relationship between the suspect therapies and the varicella, rash and movement disorder was not provided.
Within 5 min of administration, pt states ge felt lightheaded and passed out.  Pt was seated and under care of RN.  RN secured pt's airway and applied sternal rub to which the pt quickly revived.  VS were normal.  EMS was called and pt refused to go.  Pt felt much improved within 45 min of the event and left the clinic w/o  further incident.
Received 1st Pfizer covid shot on January 13, 2021 and had a massive stroke on the morning of Feb 11, 2021. Was hospitalized and passed away the following day, Feb 12, 2021.
This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient. A 67-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20Jan2021 as dose 1, single (Lot number: EL3249), in right arm, on 09Feb2021 as dose 2, single (Lot number: EM9810), in right arm and on 29Sep2021 as dose 3 (booster), single (Lot number: FC3183) at the age of 66 years, in right arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 03May2022 as dose 4 (booster), single (Lot number: 057M21A), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Obesity" (unspecified if ongoing); "mild coronary artery disease" (unspecified if ongoing). The patient had no known allergies. Concomitant medication(s) included: IMDUR; PRAVACHOL. The patient received other medication in two weeks. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Negative, notes: treatment I test negative for Covid on Day 11 and 12; (2022) Positive, notes: I tested positive with an antigen test. Therapeutic measures were taken as a result of vaccination failure, covid-19. The patient received anti-viral treatment for COVID-19, treatment start date 24Jul2022 and treatment stop date 28Jul2022. Clinical course: After completing Paxlovid 5-day treatment the patient test negative for Covid on Day 11 and 12. On Day 13, the patient began feeling achy, very tired, return of sore throat and runny nose. The patient tested positive with an antigen test and resumed second period of isolation and quarantine. Adverse event start date reported as 04Aug2022 at 17:00. The adverse event was not resulted in physician office or emergency room visit. Sender's Comments: Based on the information given in narrative, the causal relationship between the events vaccination failure and COVID-19 and the suspect drug BNT162B2 cannot be excluded.
The day of vaccine I was very tired. The next day I felt fine but by dinner time just felt like I was getting a cold. The fever and body aches began. By Monday the 2nd I began to feel as if I had a bad head cold. I had a fever and could barely move. By Thursday the 5th I was very ill and the coughing had begun. I saw the doctor who believed it was merely bronchitis. By Monday the 9th the cough had been so bad, even with medication, I had pulled all muscles in my back and torn something in my stomach. I had called the doctor again on the 11th and my doctor's associate had then given me a second dose of a different antibiotic. She also ordered a chest X-ray which  she said "showed my lungs cloudy but did not see pneumonia". I felt a bit better after 3 days of the new antibiotics. To date I am still coughing but not what I had suffered during the 3 weeks of suffering.  Furthermore my left arm is in constant pain and I am unsure if I have pulled a muscle, pinched a nerve or caused damaged to my neck due to the excessive coughing.
Information has been received from a physician concerning an 82 year old female who on 09-MAR-2007 was vaccinated with a dose of Pneumovax 23. On 09-MAR-2007 the patient developed right arm swelling post vaccination. The patient sought unspecified medical attention. At the time of this report, the outcome was unknown. Additional information has been requested.
Hypotensive and hyporesponsive episode X 3 hours, post vax.
Severe intolerable pain from clavicule to ear and from back to skull to the spinal bone. Fever of 103. Still have a fever of 100, sweats, flu-like symptoms, total debilitation.
Felt faint (almost passed out); couldn't walk right (temporary): had to lie down for less than half hour.
Administration of GARDASIL to 12 month old instead of ordered Varicella. No known adverse event.
Lymphadenopathy, swelling at site, pain, tenderness, hot flashes.
Hives on face, near eyes, chicks, necks. Chest, heart pain.  It got better but took a long time to recover. I had chest pain whenever I felt tired.  These symptoms last like couple weeks.
I was tested positive on 1/15 for Covid exp dizziness couldn't stand by yourself.
Patient developed Shingles 4 days after receiving the vaccine on the left side of her chest, prescribed gabapentin, lidoderm patches.
Patient completed Pfizer COVID-19 vaccination on 2/2/21. Lot number and site not specified in medical record. Patient was admitted to the reporting hospital on 8/26/21 with an admitting diagnosis of COVID-19 pneumonia. Patient was reported in the ER to have a productive cough, malaise, fatigue and fever. No known COVID exposure, but did come from congregate living settings. Admission test for COVID was positive per PCR NP swab on 8/26/21.
Notified by medical examiner that patient was found deceased at home 10/08/2021, no report of symptoms in interim
Abnormal uterine bleeding and diarrhea, 5/7 to 5/9
Pt recvd 3 dose schedule ofHeptavax in 1989 & recvd Engerix-B APR90 & exp failure to seroconvert.
Pt rec'd ZOSTAVAX 6/25/12. Over next 2 days pt developed large red welt. Pt says is sore to touch; it is red.
Administered vaccine from vial that had been opened for 24 hours and 30 minutes since original puncture.
Information has been received from a physician concerning a 24 year old female patient with no known allergies who on 22-OCT-2009 was vaccinated with a first dose of GARDASIL. Concomitant therapy included "birth control" that the patient has been taking for a long time. Immediately post-vaccination the patient became diaphoretic, pale, lips blue and became unresponsive for 3 to 4 seconds. Code blue was called and oxygen administered. Blood pressure readings were 110/60 and 124/80, and her pulse was 102. The patient recovered in the office and was able to drive herself home. During a follow-up conversation the patient indicated to the physician that she fully recovered. Follow up information has been received from a licensed practical nurse who confirmed that on 22-OCT-2009 the patient was vaccinated with a first dose of GARDASIL (Lot #663558/0819Y). The patient did not receive any concomitant vaccination at that time. Follow up information has been received from a licensed practical nurse who indicated that a Code Blue was called when the patient became diaphoretic, pale, lips blue and became unresponsive for 3 to 4 seconds. She explained that Code Blue is an urgent Care Response. The responders are Urgent Care Physicians and also certain members of the staff that are trained to respond in an emergency. The patient regained consciousness quickly and the patient stated that she felt better. Oxygen was administered as safety precaution only. The patient recovered. Additional information has been requested.
Able to walk into pharmacy on Nov 5, 2021 to get vaccine.  The next day, legs weak and off balance and has fallen x4 in past 10 days since the vaccine.
Described previously. Miserable. Fever, chills, tingling hands and feet, sleepy, extreme arm pain. Miserable.
Fever, chills, body aches, I'm fine, but have felt miserable all day. The doctor said there were no side effects. I thought about going home from work because I feel crummy.
Information has been received from a registered nurse concerning a 9 year old male who on 3/28/2005 was vaccianted with a dose of varicella virus vaccine live. On 6/22/2005 the patient presented to the physician with a red raised rash on his chest. No other symptoms were noted. It was reported that as of 6/24/2005 the patient was recovering. No product quality complaint was noted.
Pt Complaints of left arm pain - Took Blood pressure and it was  168/120-Code Assist called.
Patient received vaccine on 7/1/19. Presented to office today on 7/3/19 with s/s of tenderness at Injection site and decreased mobility of left arm. Patient assessed by PCP, s/s improving.
Patient got Fluzone HD around noon (9/28/20). Per patient: adverse event with symptoms of intense pain radiating from left arm including soreness all over body that got worse with time. He came back to the pharmacy the next morning (9/29/20), purchased a sling support; patient says that help with the pain a little but pain is still intense that he can barely lift his arm and now interfere with his sleep. He said he's taken Tylenol but that didn't help. He talked to his doctor about the problems and been told to come see his doctor if symptoms persist. Talked to patient today (9/30/20), he says that he is going to see his doctor tomorrow (10/1/20) as he is still in a lot of pain.
Blotchey area red sl welted 2 1/2" proximal to where recv DTP in LA; yesterday red & swollen where shot given, today no reddness but still swollen has been taking APAP;
3 min post vax, pt crumpled to floor in faint; 20 sec later arched back, rigid, eyes rolled in head, jaw & hands clenched then arched back toward body; episode lasted 10-15sec; nausea, tiredness, speech slurred, loose control; HR & resp irr